GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factors

$611,800
Sumita Bhaduri-McIntosh · University Of Florida · R01 · FY2023 · DE

An integrated microtechnology platform for spatially resolved mass spectrometry-based proteomics

$611,702
Sindy Kam-Yan Tang · Stanford University · R01 · FY2025 · CA

Biomarkers of Vision Loss in Children with Optic Pathway Gliomas

$611,652
Robert Andrew Avery · Children'S Hosp Of Philadelphia · R01 · FY2020 · EY

Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens

$611,615
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA

VLA-4–targeted 67Cu-LLP2A preconditioning enhances efficacy of T-cell-based adoptive immunotherapy

$611,562
Ravi Bhasker Patel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

BMP2 Regulation of Periosteal Function

$611,517
Vicki Rosen · Harvard Medical School · R01 · FY2022 · AR

Reverse transcriptase inhibitor effects on the mobilome of colon cancer

$611,476
David Tsai Ting · Massachusetts General Hospital · R01 · FY2019 · CA

MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer

$611,442
Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2019 · CA

P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment

$611,329
Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA

POTENTIATION OF ANTI-TUMOR IMMUNITY BY ONCOLYTIC VIRUS IN SITU VACCINATION

$611,086
Dmitriy Zamarin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis

$611,085
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2024 · CA

Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy

$611,011
Mary L. Disis · University Of Washington · R01 · FY2012 · CA

Pathogenesis of Lupus Nephritis

$610,985
Joseph E Craft · Yale University · R01 · FY2024 · AI

Pathogenesis of Lupus Nephritis

$610,985
Joseph E Craft · Yale University · R01 · FY2023 · AI

Pathogenesis of Lupus Nephritis

$610,985
Joseph E Craft · Yale University · R01 · FY2022 · AI

WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCE

$610,912
Kooresh Isaac Shoghi · Washington University · U24 · FY2019 · CA

Lung Macrophage Memory Development and Responses in Secondary Pneumonia and Sepsis

$610,868
Bibhuti Bhusan Mishra · University Of North Dakota · R01 · FY2021 · AI

Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)

$610,845
Xueding Wang · University Of Michigan At Ann Arbor · R01 · FY2022 · CA

Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapse

$610,829
Svetomir Nenad Markovic · Mayo Clinic Rochester · R01 · FY2023 · CA

Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response

$610,792
Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R01 · FY2023 · CA

Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia

$610,786
John Eisenbrey · Thomas Jefferson University · R01 · FY2019 · EB

Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity

$610,783
Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2024 · CA

Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity

$610,783
Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2025 · CA

Regulation of anti-tumor immunity by HDAC11

$610,695
Edward Seto · George Washington University · R01 · FY2020 · CA

Study of CAR T cells and mechanisms of resistance in pediatric brain tumors

$610,644
Anandani Nellan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA